1. Lau LG, Chng WJ, Liu TC, et al. Clinicopathological analysis of myelodysplastic syndromes according to FrenchAmerican-British classification and International Prognostic Scoring System. Ann Acad Med Singapore 2004;33:589- 95
2. Sokol RJ, Hewitt S, Booker DJ. Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes J Clin Pathol 1989;42:1088- 91
3. Young NS. Role of the immune system in the pancytopaenia of MDS and immunosuppressive therapy. Haematology 2002;146-50
4. Bennet JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-99
5. Harris NL, Jaffe ES, Dieboid J, et al. World Health Organization Classification of Neoplastic Diseases of the Haematopoietic and Lymphoid Tissues. J Clin Oncol;1999;17:3835-49